We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Vibration Technology Improves Diagnosis of Dizziness

By HospiMedica International staff writers
Posted on 02 Feb 2022
Print article
Image: Professor Bo Håkansson undergoes VEMP testing using the B250 (Photo courtesy of Johan Bodell / Chalmers University of Technology)
Image: Professor Bo Håkansson undergoes VEMP testing using the B250 (Photo courtesy of Johan Bodell / Chalmers University of Technology)
A novel vibration device allows vestibular evoked myogenic potentials (VEMP) tests to be performed at lower frequencies and volume levels.

Developed at Chalmers University of Technology (Göteborg, Sweden), audio companies Ortofon (Lolland, Denmark) and Interacoustics, and in collaboration with Sahlgrenska Academy (SA; Göteborg, Sweden), the B250 vibration device has been optimized to trigger a VEMP test, which evokes a muscle reflex contraction in the neck and eye muscles. Vestibular function can be assessed by averaging muscle activity response to each sound. The vibrating device is compatible with standardized equipment for balance diagnostics.

The biggest advantage of the B250 is that it triggers the muscle reflex at very low frequencies and volumes (maximum sound level of 75 decibels), and much lower than in current methods, which use very high sound levels, and may in fact cause permanent hearing damage. Benefits also include safer testing for children, and that patients with impaired hearing function due to chronic ear infections or congenital malformations in the ear canal and middle ear can be diagnosed for the origin of their dizziness.

“We have developed a new type of vibrating device that is placed behind the ear of the patient during the test,” said lead developer Professor Bo Håkansson, PhD, of the biomedical signals and systems unit at Chalmers. “The vibrating device is small and compact in size, and optimized to provide an adequate sound level for triggering the reflex at frequencies as low as 250 Hz, which we have found to be optimal for VEMP stimulation. Previously, no vibrating device has been available that was directly adapted for this type of test of the balance system.”

“Thanks to this bone conduction technology, the sound levels which patients are exposed to can be minimized. The previous test was like a machine gun going off next to the ear – with this method it will be much more comfortable,” said Karl-Johan Fredén Jansson, PhD, also of Chalmers. “The test can be performed at 40 decibels lower than today's method using air conducted sounds through headphones. This eliminates any risk that the test itself could cause hearing damage.”

In a traditional vestibular investigation, two variants of VEMP tests are used today: air transmitted sound through headphones or bone conducted sounds via a vibrating device attached to the head. When air transmitted sounds are used, high sound levels are required, which is uncomfortable to the patient and there is a risk of hearing damage. For bone conducted sound, the sound levels are lower, but the equipment currently available on the market is large and cumbersome, and therefore difficult to use.


Related Links:
Chalmers University of Technology
Ortofon
Sahlgrenska Academy


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
X-Ray QA Meter
Piranha CT

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.